Abstract
Background: The clinical practice of restless legs syndrome (RLS) has dramatically developed in Japan since the first drug for RLS was approved in 2010. While some patients become able to manage their symptoms non-pharmacologically at some point in time, others need continuing pharmacological treatments for many years.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
